Charles Schwab Investment Management Inc Ptc Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $519 Billion
  • Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 658,828 shares of PTCT stock, worth $20.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
658,828
Previous 619,293 6.38%
Holding current value
$20.8 Million
Previous $18 Million 11.83%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$24.69 - $40.12 $976,119 - $1.59 Million
39,535 Added 6.38%
658,828 $20.1 Million
Q1 2024

May 08, 2024
BUY
$24.15 - $31.95 $202,256 - $267,581
8,375 Added 1.37%
619,293 $18 Million
Q4 2023

Feb 06, 2024
BUY
$18.07 - $29.37 $255,780 - $415,732
14,155 Added 2.37%
610,918 $16.8 Million
Q3 2023

Nov 08, 2023
BUY
$22.41 - $41.99 $521,884 - $977,863
23,288 Added 4.06%
596,763 $13.4 Million
Q2 2023

Aug 09, 2023
BUY
$40.4 - $59.1 $612,706 - $896,310
15,166 Added 2.72%
573,475 $23.3 Million
Q1 2023

May 11, 2023
SELL
$38.16 - $48.86 $63,956 - $81,889
-1,676 Reduced 0.3%
558,309 $27 Million
Q4 2022

Feb 13, 2023
BUY
$33.53 - $54.79 $419,024 - $684,710
12,497 Added 2.28%
559,985 $21.4 Million
Q3 2022

Nov 14, 2022
BUY
$41.85 - $53.85 $793,057 - $1.02 Million
18,950 Added 3.59%
547,488 $27.5 Million
Q2 2022

Aug 15, 2022
BUY
$25.6 - $45.23 $413,644 - $730,826
16,158 Added 3.15%
528,538 $21.2 Million
Q1 2022

May 13, 2022
BUY
$33.33 - $44.6 $439,989 - $588,764
13,201 Added 2.64%
512,380 $19.1 Million
Q4 2021

Feb 11, 2022
BUY
$35.36 - $41.86 $373,719 - $442,418
10,569 Added 2.16%
499,179 $19.9 Million
Q3 2021

Nov 16, 2021
SELL
$37.01 - $44.74 $159,068 - $192,292
-4,298 Reduced 0.87%
488,610 $18.2 Million
Q2 2021

Aug 16, 2021
BUY
$37.95 - $49.37 $756,836 - $984,585
19,943 Added 4.22%
492,908 $20.8 Million
Q1 2021

May 17, 2021
BUY
$46.8 - $68.92 $1.03 Million - $1.51 Million
21,964 Added 4.87%
472,965 $22.4 Million
Q4 2020

Feb 16, 2021
BUY
$47.96 - $67.64 $380,035 - $535,979
7,924 Added 1.79%
451,001 $27.5 Million
Q3 2020

Nov 13, 2020
BUY
$45.41 - $57.07 $591,783 - $743,736
13,032 Added 3.03%
443,077 $20.7 Million
Q2 2020

Aug 14, 2020
BUY
$42.56 - $54.98 $2 Million - $2.58 Million
46,893 Added 12.24%
430,045 $21.8 Million
Q1 2020

May 15, 2020
BUY
$32.37 - $59.36 $260,190 - $477,135
8,038 Added 2.14%
383,152 $17.1 Million
Q4 2019

Feb 07, 2020
BUY
$32.22 - $50.07 $727,076 - $1.13 Million
22,566 Added 6.4%
375,114 $18 Million
Q3 2019

Nov 08, 2019
BUY
$33.82 - $48.17 $960,860 - $1.37 Million
28,411 Added 8.77%
352,548 $11.9 Million
Q2 2019

Aug 09, 2019
SELL
$35.42 - $45.0 $1.18 Million - $1.5 Million
-33,294 Reduced 9.31%
324,137 $14.6 Million
Q1 2019

May 14, 2019
BUY
$28.09 - $39.49 $1.08 Million - $1.52 Million
38,487 Added 12.07%
357,431 $13.5 Million
Q4 2018

Feb 14, 2019
BUY
$29.83 - $46.51 $1.08 Million - $1.68 Million
36,090 Added 12.76%
318,944 $10.9 Million
Q3 2018

Nov 13, 2018
SELL
$33.9 - $47.77 $433,275 - $610,548
-12,781 Reduced 4.32%
282,854 $13.3 Million
Q2 2018

Aug 08, 2018
BUY
$25.7 - $47.88 $1.86 Million - $3.46 Million
72,308 Added 32.38%
295,635 $9.97 Million
Q1 2018

May 07, 2018
BUY
$17.46 - $32.59 $608,288 - $1.14 Million
34,839 Added 18.48%
223,327 $6.04 Million
Q4 2017

Jan 17, 2018
BUY
$15.14 - $20.89 $146,752 - $202,486
9,693 Added 5.42%
188,488 $3.14 Million
Q3 2017

Nov 13, 2017
BUY
$16.81 - $21.61 $3.01 Million - $3.86 Million
178,795
178,795 $3.58 Million

Others Institutions Holding PTCT

# of Institutions
215
Shares Held
79.2M
Call Options Held
122K
Put Options Held
212K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.26B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email